OrthoPediatrics Corp
NASDAQ:KIDS
Intrinsic Value
OrthoPediatrics Corp. is a medical device company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. [ Read More ]
The intrinsic value of one KIDS stock under the Base Case scenario is 32.92 USD. Compared to the current market price of 28.97 USD, OrthoPediatrics Corp is Undervalued by 12%.
Valuation Backtest
OrthoPediatrics Corp
Run backtest to discover the historical profit from buying and selling KIDS stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Robust Q4 Earnings and Positive 2024 Outlook
2023-Q4 Earnings Call
In Q4 2023, the company's revenue soared to $37.6 million, a 21% jump from the previous year, led by strong global Trauma and Deformity sales, solid domestic Scoliosis performance, and OPSB growth. U.S. sales alone ballooned by 24%, reaching $28.3 million. Despite headwinds from soft scoliosis demand in South America, international revenue climbed 13% to $9.3 million. Set deployments maintained a robust pace with $5.9 million consigned. Gross profit margins nudged higher to 71.0% from 68.5%. Operating expenses rose by 18%, in line with business growth and elevated R&D efforts, which surged by 35%. Yet, the company achieved an adjusted EBITDA of $1.3 million, reversing a loss from the same quarter last year. Full-year guidance remains strong, predicting revenues between $197 million and $200 million, equating to a 32-34% increase, and aiming for an adjusted EBITDA from $8.0 to $9.0 million.
Balance Sheet Decomposition
OrthoPediatrics Corp
Current Assets | 226.5m |
Cash & Short-Term Investments | 80.3m |
Receivables | 34.6m |
Other Current Assets | 111.6m |
Non-Current Assets | 212.2m |
PP&E | 41m |
Intangibles | 168.3m |
Other Non-Current Assets | 2.9m |
Current Liabilities | 41.7m |
Accounts Payable | 12.6m |
Accrued Liabilities | 11.3m |
Other Current Liabilities | 17.7m |
Non-Current Liabilities | 20.1m |
Long-Term Debt | 9.9m |
Other Non-Current Liabilities | 10.1m |
Earnings Waterfall
OrthoPediatrics Corp
Revenue
|
148.7m
USD
|
Cost of Revenue
|
-37.5m
USD
|
Gross Profit
|
111.3m
USD
|
Operating Expenses
|
-137m
USD
|
Operating Income
|
-25.8m
USD
|
Other Expenses
|
4.8m
USD
|
Net Income
|
-21m
USD
|
Free Cash Flow Analysis
OrthoPediatrics Corp
What is Free Cash Flow?
KIDS Profitability Score
Profitability Due Diligence
OrthoPediatrics Corp's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
Score
OrthoPediatrics Corp's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
KIDS Solvency Score
Solvency Due Diligence
OrthoPediatrics Corp's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
OrthoPediatrics Corp's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
KIDS Price Targets Summary
OrthoPediatrics Corp
According to Wall Street analysts, the average 1-year price target for KIDS is 40.29 USD with a low forecast of 32.32 USD and a high forecast of 52.5 USD.
Ownership
KIDS Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
KIDS Price
OrthoPediatrics Corp
Average Annual Return | 2.62% |
Standard Deviation of Annual Returns | 36.23% |
Max Drawdown | -68% |
Market Capitalization | 677.3m USD |
Shares Outstanding | 23 550 000 |
Percentage of Shares Shorted | 6.8% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
OrthoPediatrics Corp. is a medical device company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. The company is headquartered in Warsaw Indiana, Indiana and currently employs 133 full-time employees. The company went IPO on 2017-10-12. The firm operates through the OrthoPediatrics Segment, which designs, develops and markets anatomically appropriate implants and devices for children with orthopedic problems. The company offers a range of products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform Femur, Orthex, QuickPack and ApiFix Mid-C System, to various hospitals and medical facilities throughout the United States and various international markets. The company markets approximately 37 surgical systems that address pediatric trauma and deformity correction, scoliosis and sports medicine/other procedures.
Contact
IPO
Employees
Officers
The intrinsic value of one KIDS stock under the Base Case scenario is 32.92 USD.
Compared to the current market price of 28.97 USD, OrthoPediatrics Corp is Undervalued by 12%.